MedImmune, a medicine provider based in Gaithersburg, has unveiled a new, state-of-the-art pilot lab facility located on the same site as its headquarters.
The facility will support MedImmune?s expanding clinical product pipeline by providing additional capacity and flexibility. The lab?s 5,000 liters of bioreactor capacity will result in a four-fold increase in production capabilities.
Stay informed.Stay ahead.
Join Washington Examiner for unlimited access to the news, analysis, and commentary that matter most.
See Options
Already a member? Log in
Already a print subscriber? Click here to login/register your account
